Press releases

13 Oct 2020

COVID-19: first set of specific healthcare recommendations issued for people living with Chagas disease

Press releases

1 Oct 2020

DNDi welcomes GHIT Fund support for Phase I trial of novel treatment for cutaneous leishmaniasis

Press releases

29 Sep 2020

DRC: The Ministry of Health and DNDi launch a project designed to facilitate access to new treatments against sleeping sickness

Press releases

28 Sep 2020

Fundación MEDINA, DNDi, and Institut Pasteur Korea announce new funding from “la Caixa” Health Research for research partnership to discover new natural products against leishmaniasis and Chagas disease

Press releases

4 Sep 2020

Innovative single-dose oral sleeping sickness treatment to be co-developed by Sanofi and DNDi partnership

Press releases

13 May 2020

DNDi short film about new treatment for sleeping sickness awarded Grand Prix at inaugural WHO film festival

Press releases

14 Apr 2020

Up to 45,000 people living with Chagas disease in the US at risk of severe COVID-19 complications

Press releases

13 Apr 2020

Marking World Chagas Day for the first time to help give visibility to this neglected disease

Press releases

2 Apr 2020

Coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries

Press releases

25 Feb 2020

Novartis and DNDi to collaborate on the development of a new oral drug to treat visceral leishmaniasis

Press releases

5 Dec 2019

Brazil’s Ministry of Health and CNPq to invest in researching new treatments for leishmaniasis and Chagas disease

Press releases

29 Nov 2019

HIV treatment for children to be produced for under one dollar a day

Press releases

28 Nov 2019

Public-private partnership launched to develop new drugs for roundworm infections

Press releases

27 Nov 2019

Research for new drugs against neglected diseases and malaria in Brazil to receive funding boost totaling BRL 43.5 million

Press releases

25 Nov 2019

Efforts to register new hepatitis C treatment in Malaysia receive support from Pharmaniaga

Press releases

25 Nov 2019

DNDi receives $29 million to fast-track the development of drugs to help eliminate sleeping sickness and river blindness